The Asian Scientist 100
Bin Liu
Institution
National University of Singapore
Country
Singapore
Field
Materials Sciences
Liu received the Public Administration Medal (Silver), National Day Awards 2023 for her contributions to the field of organic functional materials. She has made significant breakthroughs in polymer chemistry and applications of organic nanomaterials for biomedical, environmental and energy research.
AWARDS
- Public Administration Medal (Silver), National Day Awards 2023
Related articles
So You Want To Be A Doctor? Be Prepared For The Ride Of Your Life
Seven doctors with extraordinary career paths shed light on the many options beyond medical school at Wildype Media Group’s ‘So You Want To Be A Doctor’ seminar.
2019 Edition Of Asian Scientist 100 Announced
Each year, Asian Scientist Magazine highlights 100 outstanding thinkers and innovators from Asia who are pushing the envelope with their research.
Single Cells Move To A Different Beat
Unlike their unicellular counterparts, aggregated social amoebae need physical contact to get them going, say researchers from Japan.
MRIs Made With Patients In Mind
Breakthrough MRI technologies promise better quality images in a shorter span of time without compromising patient comfort.
What’s Different About Asia?
Upon learning firsthand that Asian and Caucasian patients responded differently to cancer drugs, John Wong founded the Cancer Therapeutics Research Group to study these differences.
Folding Drugs Into DNA Origami To Kill Tumors
Scientists in China have devised a nanotechnology platform to deliver interfering RNAs and anticancer drugs to tumors.
Bamboo And Rattan Genomes Sequenced
Researchers of the Genome Atlas of Bamboo and Rattan Consortium have published a chromosome-level genome assembly of moso bamboo and two representative rattan genomes.
Turning Soy Pulp Into A Probiotic Drink
Scientists in Singapore have used a cocktail of enzymes, probiotics and yeast to produce a nutrient-rich beverage from food waste.
A Peptide That Protects Against Liver Cancer
Scientists in Singapore have developed a peptide drug that interferes with a molecular interaction that drives liver cancer progression.